CPHA Canvax
PDF

"This document provides a summary of the NACI statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine." - Summary of NACI statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine


Download

Related Resources

Bookmark

Implementation Tool

PDF

Category

Vaccine Safety and Development,Vaccine Safety,Vaccine Safety,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19,Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Vaccine Management,Allocation and Distribution,Storage and Handling Vaccine Safety and Development
Vaccine Safety
Vaccine Safety
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Program Planning and Delivery
Program Delivery and Evaluation
Clinics
Vaccine Management
Allocation and Distribution
Storage and Handling

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.